In the landscape of modern rehabilitation, the integration of controlled thermal exchange and intermittent compression has set a new clinical gold standard. As a premier manufacturer, we specialize in "Thermotek-grade" cold therapy units that bridge the gap between hospital-grade recovery and portable home-use efficiency.
Founded in 2009, Tianjin Konbest Technology (Production in Guangzhou) brings over 17 years of specialized R&D. With ISO13485 and FDA compliance, we offer more than just manufacturing—we provide the scientific authority required by the global medical community.
The global sports medicine market is projected to reach $11B by 2028. Our OEM solutions cater to professional sports franchises, orthopedic clinics, and private wellness brands looking for "information gain" via superior tech integration.
Factory sq. meters
Monthly Capacity
Years Experience
5-Star Reviews
In the pursuit of optimized recovery, the OEM Thermotek Cold Therapy Unit has emerged as a critical asset for healthcare providers worldwide. Traditional icing methods are being phased out in favor of active systems that provide synchronized cooling and compression. This "active" mechanism mimics natural muscle contractions, facilitating lymph drainage and significantly reducing the inflammatory response post-surgery or post-injury.
The shift in procurement behavior among Tier-1 hospital groups and elite athletic organizations shows a move toward "Information Gain" procurement. Buyers are no longer seeking just "chillers"; they are seeking integrated data-driven recovery units. Modern procurement requirements now prioritize:
• Customizable Pressure Gradient: Essential for treating different stages of edema.
• Peltier-Based Thermoelectric Cooling: Eliminating the need for ice in professional settings.
• Biocompatible Interface Materials: Ensuring patient safety during prolonged contact.
At KONBEST, our technical roadmap focuses on the intersection of AI and Thermal Science. By 2026, our "Next-Gen" units will feature Intelligent Thermal Profiling, where the unit adjusts output based on the skin surface temperature sensor feedback. This prevents thermal shock and optimizes the metabolic rate reduction necessary for tissue healing.
Currently, the industry is seeing a consolidation of manufacturing centers. Guangzhou, China, remains the epicenter for high-end therapy equipment due to its robust PCBA supply chain and advanced textile engineering for therapy wraps. We have integrated these advantages to offer full-lifecycle OEM/ODM support, moving from initial industrial design (ID) to final FDA-registered mass production within accelerated timelines.
From concept to delivery, we provide PCB design, mold manufacturing, and customized software firmware for medical applications.
Our products meet CE, MDR, FDA, and FCC standards, ensuring smooth entry into North American and European markets.
With 10 senior engineers, we can deliver functional prototypes in record time, allowing you to capture market trends faster.
Yes. We assist our partners in localizing documentation for FDA (USA), CE/MDR (Europe), and TGA (Australia). Our facility is ISO13485 certified, which is the prerequisite for most global medical device registrations.
For standard models with custom branding, lead times are 3-4 weeks. For full ODM projects (new mold), the timeline typically spans 3-6 months from concept to mass production.
Absolutely. Our firmware supports customizable compression cycles (Intermittent vs. Sequential) and pressure ranges (up to 260mmHg) to match specific post-operative protocols.
We provide a 1-2 year warranty depending on the product line. We also offer "White-Label" technical manuals and 24/7 video support for your local service teams.
By 2025, KONBEST aims to exceed 1 billion yuan in revenue, driven by our commitment to "Green Therapy." We are currently developing biodegradable therapy wraps and energy-efficient cooling engines that reduce electricity consumption by 30%. As we innovate, our focus remains on providing our OEM partners with the competitive edge needed to lead the market in rehabilitation and home healthcare.